BlackRock Institutional Trust’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BFA
BlackRock Institutional Trust's AGN Position: Q4 2016 in Review
BlackRock Institutional Trust reduced its Allergan plc (AGN) stake by 6.2% in Q4 2016, selling an estimated $133M and leaving 9,621,675 shares worth $2.02B. The position accounts for 0.3% of the portfolio, ranked #59.
BlackRock Institutional Trust first reported a position in AGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.16B in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.
- BlackRock Institutional Trust held 9,621,675 shares of Allergan plc worth $2.02B as of Q4 2016.
- BlackRock Institutional Trust sold 640,337 Allergan plc shares in Q4 2016, an estimated $133M.
- Allergan plc made up 0.3% of BlackRock Institutional Trust's portfolio in Q4 2016, its #59 holding.
- BlackRock Institutional Trust first reported a position in Allergan plc in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Allergan plc position peaked at $3.16B in Q4 2015.
- 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.